Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Noted Drug Development Authority Dr. Hans Van Bronswijk Expands PAREXEL Consulting's European Practice
August 31st, 2007
PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ:PRXL) and a leading global life sciences consultancy serving the bio/pharmaceutical and medical device industries, has appointed Dr. Hans Van Bronswijk to the position of Principal Consultant in its European Drug Development Practice. In this role, Dr. Van Bronswijk will advise clients on all aspects of clinical development and regulatory affairs. With in-depth knowledge of drug development and European Union (EU) regulatory procedures, Dr. Bronswijk will help PAREXEL clients effectively navigate the increasingly complex development and regulatory environment. Dr. Van Bronswijk served on the Dutch Medicines Evaluation...
Source: Drug Week (2007-08-31)
|
|
Advertisement |
|
|
|
